Overview

Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of hydromorphone hydrochloride administered by intrathecal delivery.
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Piramal Critical Care, Ltd.
Treatments:
Hydromorphone